PHARMACEUTICAL PRODUCT DEVELOPMENT INC Acquisitions, Net of Cash Acquired
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Acquisitions, Net of Cash Acquired of $7.94 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire businesses, net of cash acquired for the quarter ending 2011-09-30 was $0.00.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire businesses, net of cash acquired for the quarter ending 2011-06-30 was $7.41M, a 26.76% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire businesses, net of cash acquired for the quarter ending 2011-03-31 was $523.00K, a 989.58% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire businesses, net of cash acquired for the quarter ending 2010-12-31 was $12.97M, a 82.31% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire businesses, net of cash acquired for fiscal 2010 was $23.14M, a 80.71% decline from fiscal 2009.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire businesses, net of cash acquired for fiscal 2009 was $119.92M, a 272.32% increase from fiscal 2008.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire businesses, net of cash acquired for fiscal 2008 was $32.21M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $7.41M derived: sum of 2 quarters · filed 2011-11-02 | $7.94M 10-Q · filed 2011-11-02 | $20.90M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-06-30 | $7.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $7.94M 10-Q · filed 2011-08-04 | $20.90M derived: sum of 3 quarters · filed 2011-08-04 | $20.90M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-03-31 | $523.00K 10-Q · filed 2011-05-03 | $13.49M derived: sum of 2 quarters · filed 2011-05-03 | $13.49M derived: sum of 3 quarters · filed 2011-11-02 | $23.61M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-12-31 | $12.97M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $12.97M derived: sum of 2 quarters · filed 2011-11-02 | $23.09M derived: sum of 3 quarters · filed 2011-11-02 | $23.14M 10-K · filed 2011-02-25 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $10.12M derived: sum of 2 quarters · filed 2011-11-02 | $10.17M 10-Q · filed 2011-11-02 | $83.47M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-06-30 | $10.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $10.17M 10-Q · filed 2011-08-04 | $83.47M derived: sum of 3 quarters · filed 2011-08-04 | $95.07M derived: sum of 4 quarters · filed 2011-08-04 |
| 2010-03-31 | $48.00K 10-Q · filed 2011-05-03 | $73.35M derived: sum of 2 quarters · filed 2011-05-03 | $84.95M derived: sum of 3 quarters · filed 2011-05-03 | |
| 2009-12-31 | $73.30M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $84.90M derived: sum of 2 quarters · filed 2011-02-25 | $119.92M 10-K · filed 2011-02-25 | |
| 2009-09-30 | $11.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $46.62M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $35.02M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $32.21M 10-K · filed 2011-02-25 |